Inretio

Ischemic Stroke Treatment

Health Tech & Life Sciences
Active
Series A Nir Am, Israel Founded 2017
Last updated 2026-06-18
Total raised
$2.5M
Last: 2023-02
Stage
Series A
Founded
2017
Headcount
10
HQ
Nir Am, Israel
Sector
Health Tech & Life Sciences

About

Inretio develops solutions that address complications during clot retrieval procedures for ischemic stroke treatment.

Funding history · 1 round · $2.5M total

2023-02

Q&A

What is Inretio's primary focus?
Inretio develops solutions to address complications during clot retrieval procedures for ischemic stroke treatment.
When was Inretio founded?
Inretio was founded in December 2017.
Where is Inretio headquartered?
Inretio is headquartered in Nir Am, South District, Israel.
What is Inretio's primary sector?
Inretio's primary sector is Health Tech & Life Sciences.
What is Inretio's current product stage?
Inretio's product is in the R&D stage.
What is Inretio's total amount raised to date?
Inretio has raised a total of $2,500,000 USD.
When was Inretio's last funding round and who participated?
In February 2023, Inretio closed a funding round with participation from Therma Bright.
What is Inretio's current funding stage?
Inretio is currently in its Series A funding stage.

Team · 1

Founder · Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Tags

treatmentsmedical-devicesstroke
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteinretio.co.il
LinkedInlinkedin.com/company/68842510

Identifiers & details

Founded2017-12
Employees (exact)10

Radar intelligence

Patents

EPO3

GitHub

Top reposbash-it, WordPress-Plugin-Boilerplate

Web history (Wayback)

Domaininretio.co.il